Cyclosporin compositions

Details Cyclosporin compositions Cyclosporin compositions

2007-10-02

2007-10-02

Gupta, Anish (Department: 1654)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C530S317000, C514S912000, C514S975000, C435S112000

Reexamination Certificate

active

11181187

ABSTRACT:
A composition comprising from 0.001% to about 0.4% cyclosporin A, a surfactant, and an oil selected from the group consisting of anise oil, clove oil, cassia oil, cinnamon oil, and combinations thereof, wherein said composition is an ophthalmically acceptable emulsion is disclosed herein.

REFERENCES:
patent: 4388307 (1983-06-01), Cavanak
patent: 4649047 (1987-03-01), Kaswan
patent: 4814323 (1989-03-01), Andrieu et al.
patent: 4839342 (1989-06-01), Kaswan
patent: 4996193 (1991-02-01), Hewitt et al.
patent: 5047396 (1991-09-01), Orban et al.
patent: 5051402 (1991-09-01), Kurihara et al.
patent: 5342625 (1994-08-01), Hauer et al.
patent: 5474979 (1995-12-01), Ding et al.
patent: 5543393 (1996-08-01), Kim et al.
patent: 5614491 (1997-03-01), Walch et al.
patent: 5639724 (1997-06-01), Cavanak
patent: 5652212 (1997-07-01), Cavanak et al.
patent: 5759997 (1998-06-01), Cavanak
patent: 5766629 (1998-06-01), Cho et al.
patent: 5798333 (1998-08-01), Sherman
patent: 5827822 (1998-10-01), Floc'h et al.
patent: 5834017 (1998-11-01), Cho et al.
patent: 5891846 (1999-04-01), Ishida et al.
patent: 5916589 (1999-06-01), Hauer et al.
patent: 5951971 (1999-09-01), Kawashima et al.
patent: 5962014 (1999-10-01), Hauer et al.
patent: 5962017 (1999-10-01), Hauer et al.
patent: 5962019 (1999-10-01), Cho et al.
patent: 5977066 (1999-11-01), Cavanak
patent: 6007840 (1999-12-01), Hauer et al.
patent: 6024978 (2000-02-01), Hauer et al.
patent: 6057289 (2000-05-01), Mulye
patent: 6190691 (2001-02-01), Mak
patent: 6197335 (2001-03-01), Sherman
patent: 6254860 (2001-07-01), Garst
patent: 6254885 (2001-07-01), Cho et al.
patent: 6267985 (2001-07-01), Chen et al.
patent: 6284268 (2001-09-01), Mishra et al.
patent: 6294192 (2001-09-01), Patel et al.
patent: 6306825 (2001-10-01), Cavanak
patent: 6350442 (2002-02-01), Garst
patent: 6468968 (2002-10-01), Cavanak et al.
patent: 6475519 (2002-11-01), Meinzer et al.
patent: 6486124 (2002-11-01), Olbrich et al.
patent: 6569463 (2003-05-01), Patel et al.
patent: 6582718 (2003-06-01), Kawashima et al.
patent: 6638522 (2003-10-01), Mulye
patent: 6656504 (2003-12-01), Bosch et al.
patent: 6723339 (2004-04-01), Meinzer et al.
patent: 6916785 (2005-07-01), Patel
patent: 2001/0003589 (2001-06-01), Neuer et al.
patent: 2001/0036449 (2001-11-01), Garst
patent: 2002/0012680 (2002-01-01), Patel et al.
patent: 2002/0013272 (2002-01-01), Cavanak et al.
patent: 2002/0016290 (2002-02-01), Floc'h et al.
patent: 2002/0016292 (2002-02-01), Richter et al.
patent: 2002/0025927 (2002-02-01), Olbrich et al.
patent: 2002/0045601 (2002-04-01), Kawashima et al.
patent: 2002/0107183 (2002-08-01), Petswzulat et al.
patent: 2002/0119190 (2002-08-01), Meinzer et al.
patent: 2002/0165134 (2002-11-01), Richter et al.
patent: 2003/0060402 (2003-03-01), Cavanak et al.
patent: 2003/0133984 (2003-07-01), Ambuhl et al.
patent: 2003/0143250 (2003-07-01), Hauer et al.
patent: 2003/0147954 (2003-08-01), Yang et al.
patent: 2003/0166517 (2003-09-01), Fricker et al.
patent: 2003/0211983 (2003-11-01), Petszulat et al.
patent: 2003/0215496 (2003-11-01), Patel et al.
patent: 2004/0048789 (2004-03-01), Patel
patent: 2004/0101552 (2004-05-01), Patel
patent: 2004/0102366 (2004-05-01), Patel
patent: 2004/0161458 (2004-08-01), Meinzer et al.
patent: 2004/0167063 (2004-08-01), Cavanak et al.
patent: 2004/0198645 (2004-10-01), Ambuhl et al.
patent: 2005/0048087 (2005-03-01), Posanski
patent: 2005/0059583 (2005-03-01), Acheampong et al.
patent: 2005/0118254 (2005-06-01), Choi et al.
patent: 2005/0129718 (2005-06-01), Sherman
patent: 2005/0147659 (2005-07-01), Carli et al.
patent: 0471293 (1992-02-01), None
patent: WO 00/00179 (2000-01-01), None
patent: WO 2004/091578 (2004-10-01), None
Restasis®(cyclosporine ophthalmic emulsion)0.05% Sterile, Preservative-Free, (Prescribing Information), 2 pages.
Kuwano et al, “Cyclosporine A Formulation Affects Its Ocular Distribution in Rabbits”, Pharmaceutical Research, vol. 19, No. 1, Jan. 2002, 108-111.

Affiliated with

Also associated with

Rating

Cyclosporin compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cyclosporin compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclosporin compositions will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3868087